- Home
- NEO vs CTS Comparison
NEO vs CTS Comparison
Compare NEO & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- CTS
- Stock Information
- Founded
- NEO 2001
- CTS 1896
- Country
- NEO United States
- CTS United States
- Employees
- NEO N/A
- CTS N/A
- Industry
- NEO Precision Instruments
- CTS Electrical Products
- Sector
- NEO Health Care
- CTS Technology
- Exchange
- NEO Nasdaq
- CTS Nasdaq
- Market Cap
- NEO 1.2B
- CTS 1.2B
- IPO Year
- NEO 1999
- CTS N/A
- Fundamental
- Price
- NEO $10.13
- CTS $41.02
- Analyst Decision
- NEO Buy
- CTS
- Analyst Count
- NEO 10
- CTS 0
- Target Price
- NEO $12.56
- CTS N/A
- AVG Volume (30 Days)
- NEO 4.9M
- CTS 244.4K
- Earning Date
- NEO 10-28-2025
- CTS 10-28-2025
- Dividend Yield
- NEO N/A
- CTS 0.39%
- EPS Growth
- NEO N/A
- CTS 3.07
- EPS
- NEO N/A
- CTS 1.98
- Revenue
- NEO $709,162,000.00
- CTS $531,522,000.00
- Revenue This Year
- NEO $10.74
- CTS $3.90
- Revenue Next Year
- NEO $9.85
- CTS $6.50
- P/E Ratio
- NEO N/A
- CTS $20.72
- Revenue Growth
- NEO 10.10
- CTS 3.61
- 52 Week Low
- NEO $4.72
- CTS $34.02
- 52 Week High
- NEO $19.12
- CTS $59.68
- Technical
- Relative Strength Index (RSI)
- NEO 56.70
- CTS 53.09
- Support Level
- NEO $9.42
- CTS $40.83
- Resistance Level
- NEO $10.75
- CTS $43.37
- Average True Range (ATR)
- NEO 0.54
- CTS 1.66
- MACD
- NEO -0.07
- CTS 0.09
- Stochastic Oscillator
- NEO 36.66
- CTS 71.97
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.